CompletedPhase 1NCT04139577

FMT In High-Risk Acute GVHD After ALLO HCT

Studying Graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Zachariah DeFilipp, MD
Masachusetts General Hospital
Intervention
Fecal Microbiota Transplant(biological)
Enrollment
10 target
Eligibility
18 years · All sexes
Timeline
2021 – 2023

Study locations (1)

Collaborators

American Cancer Society, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04139577 on ClinicalTrials.gov

Other trials for Graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Graft versus host disease →

← Back to all trials